Impact of diabetes status on immunogenicity of trivalent inactivated influenza vaccine in older adults
Individuals with type 2 diabetes mellitus experience high rates of influenza virus infection and complications. We compared the magnitude and duration of serologic response to trivalent influenza vaccine in adults aged 50–80 with and without type 2 diabetes mellitus. Serologic response to influenza...
Gespeichert in:
Veröffentlicht in: | Influenza and other respiratory viruses 2022-05, Vol.16 (3), p.562-567 |
---|---|
Hauptverfasser: | , , , , , , , , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 567 |
---|---|
container_issue | 3 |
container_start_page | 562 |
container_title | Influenza and other respiratory viruses |
container_volume | 16 |
creator | Spencer, Sarah Chung, Jessie R. Belongia, Edward A. Sundaram, Maria Meece, Jennifer Coleman, Laura A. Zimmerman, Richard K. Nowalk, Mary Patricia Moehling Geffel, Krissy Ross, Ted Carter, Chalise E. Shay, David Levine, Min Liepkalns, Justine Kim, Jin Hyang Sambhara, Suryaprakash Thompson, Mark G. Flannery, Brendan |
description | Individuals with type 2 diabetes mellitus experience high rates of influenza virus infection and complications. We compared the magnitude and duration of serologic response to trivalent influenza vaccine in adults aged 50–80 with and without type 2 diabetes mellitus. Serologic response to influenza vaccination was similar in both groups: greater fold‐increases in antibody titer occurred among participants with lower pre‐vaccination antibody titers. Waning of antibody titers was not influenced by diabetes status. |
doi_str_mv | 10.1111/irv.12933 |
format | Article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8983908</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2647051698</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4433-e1fda1ad7c9cf97fa8d78a9142732980b309e949e7ca2cb532e4772b14b9a5d93</originalsourceid><addsrcrecordid>eNp1kd2LVCEYhyWK9qMu-gfiQDd1Mbt-Ho83QSy1DSwEUd2KR9-zuXh0Us_E9NfnNNtQQd74qo-Pr_wQekbwBWnj0uftBaGKsQfolEiBV7QX6uGx5vgEnZVyh7HoB8EfoxPGB6HEwE_RtJ43xtYuTZ3zZoQKpSvV1KV0KXZ-npeYbiF66-tuD9XstyZArJ2P7V5bVHCtnsIC8YfptsZaH6HtdCk4yJ1xS6jlCXo0mVDg6f18jj6_e_vp6v3q5sP1-urNzcpyztgKyOQMMU5aZSclJzM4ORhFOJWMqgGPDCtQXIG0htpRMApcSjoSPiojnGLn6PXBu1nGGZxtjWYT9Cb72eSdTsbrv0-i_6pv01YPamAKD03w8l6Q07cFStWzLxZCMBHSUjTtca8okXj_1ot_0Lu05Ni-1ygusSC92gtfHSibUykZpmMzBOt9erqlp3-l19jnf3Z_JH_H1YDLA_DdB9j936TXH78clD8BVU-mlA</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2647051698</pqid></control><display><type>article</type><title>Impact of diabetes status on immunogenicity of trivalent inactivated influenza vaccine in older adults</title><source>MEDLINE</source><source>Wiley Online Library Open Access</source><source>DOAJ Directory of Open Access Journals</source><source>Wiley Online Library Journals Frontfile Complete</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>PubMed Central</source><creator>Spencer, Sarah ; Chung, Jessie R. ; Belongia, Edward A. ; Sundaram, Maria ; Meece, Jennifer ; Coleman, Laura A. ; Zimmerman, Richard K. ; Nowalk, Mary Patricia ; Moehling Geffel, Krissy ; Ross, Ted ; Carter, Chalise E. ; Shay, David ; Levine, Min ; Liepkalns, Justine ; Kim, Jin Hyang ; Sambhara, Suryaprakash ; Thompson, Mark G. ; Flannery, Brendan</creator><creatorcontrib>Spencer, Sarah ; Chung, Jessie R. ; Belongia, Edward A. ; Sundaram, Maria ; Meece, Jennifer ; Coleman, Laura A. ; Zimmerman, Richard K. ; Nowalk, Mary Patricia ; Moehling Geffel, Krissy ; Ross, Ted ; Carter, Chalise E. ; Shay, David ; Levine, Min ; Liepkalns, Justine ; Kim, Jin Hyang ; Sambhara, Suryaprakash ; Thompson, Mark G. ; Flannery, Brendan</creatorcontrib><description>Individuals with type 2 diabetes mellitus experience high rates of influenza virus infection and complications. We compared the magnitude and duration of serologic response to trivalent influenza vaccine in adults aged 50–80 with and without type 2 diabetes mellitus. Serologic response to influenza vaccination was similar in both groups: greater fold‐increases in antibody titer occurred among participants with lower pre‐vaccination antibody titers. Waning of antibody titers was not influenced by diabetes status.</description><identifier>ISSN: 1750-2640</identifier><identifier>EISSN: 1750-2659</identifier><identifier>DOI: 10.1111/irv.12933</identifier><identifier>PMID: 34859584</identifier><language>eng</language><publisher>England: John Wiley & Sons, Inc</publisher><subject>Adults ; Aged ; Aged, 80 and over ; Antibodies ; Antibodies, Viral ; Antigens ; Complications ; Diabetes ; Diabetes mellitus ; Diabetes mellitus (non-insulin dependent) ; Diabetes Mellitus, Type 2 ; Enrollments ; Guillain-Barre syndrome ; Hemagglutination Inhibition Tests ; Humans ; Immunogenicity ; Influenza ; Influenza A Virus, H3N2 Subtype ; Influenza Vaccines ; Influenza, Human - prevention & control ; Laboratories ; Memory ; Middle Aged ; Obesity ; Older people ; Original ; Regression analysis ; Respiratory diseases ; serologic response ; Serology ; Vaccination ; vaccine ; Vaccines ; Vaccines, Inactivated ; Viruses ; Vitamin D</subject><ispartof>Influenza and other respiratory viruses, 2022-05, Vol.16 (3), p.562-567</ispartof><rights>Published 2021. This article is a U.S. Government work and is in the public domain in the USA. published by John Wiley & Sons Ltd.</rights><rights>Published 2021. This article is a U.S. Government work and is in the public domain in the USA. Influenza and Other Respiratory Viruses published by John Wiley & Sons Ltd.</rights><rights>2022. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4433-e1fda1ad7c9cf97fa8d78a9142732980b309e949e7ca2cb532e4772b14b9a5d93</citedby><cites>FETCH-LOGICAL-c4433-e1fda1ad7c9cf97fa8d78a9142732980b309e949e7ca2cb532e4772b14b9a5d93</cites><orcidid>0000-0001-9619-4820 ; 0000-0003-1947-7469 ; 0000-0001-6786-3482 ; 0000-0002-2103-4096 ; 0000-0001-5205-966X ; 0000-0001-8056-3302 ; 0000-0002-1702-2690 ; 0000-0001-7478-0415</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8983908/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8983908/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,860,881,1411,11543,27903,27904,45553,45554,46030,46454,53769,53771</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/34859584$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Spencer, Sarah</creatorcontrib><creatorcontrib>Chung, Jessie R.</creatorcontrib><creatorcontrib>Belongia, Edward A.</creatorcontrib><creatorcontrib>Sundaram, Maria</creatorcontrib><creatorcontrib>Meece, Jennifer</creatorcontrib><creatorcontrib>Coleman, Laura A.</creatorcontrib><creatorcontrib>Zimmerman, Richard K.</creatorcontrib><creatorcontrib>Nowalk, Mary Patricia</creatorcontrib><creatorcontrib>Moehling Geffel, Krissy</creatorcontrib><creatorcontrib>Ross, Ted</creatorcontrib><creatorcontrib>Carter, Chalise E.</creatorcontrib><creatorcontrib>Shay, David</creatorcontrib><creatorcontrib>Levine, Min</creatorcontrib><creatorcontrib>Liepkalns, Justine</creatorcontrib><creatorcontrib>Kim, Jin Hyang</creatorcontrib><creatorcontrib>Sambhara, Suryaprakash</creatorcontrib><creatorcontrib>Thompson, Mark G.</creatorcontrib><creatorcontrib>Flannery, Brendan</creatorcontrib><title>Impact of diabetes status on immunogenicity of trivalent inactivated influenza vaccine in older adults</title><title>Influenza and other respiratory viruses</title><addtitle>Influenza Other Respir Viruses</addtitle><description>Individuals with type 2 diabetes mellitus experience high rates of influenza virus infection and complications. We compared the magnitude and duration of serologic response to trivalent influenza vaccine in adults aged 50–80 with and without type 2 diabetes mellitus. Serologic response to influenza vaccination was similar in both groups: greater fold‐increases in antibody titer occurred among participants with lower pre‐vaccination antibody titers. Waning of antibody titers was not influenced by diabetes status.</description><subject>Adults</subject><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Antibodies</subject><subject>Antibodies, Viral</subject><subject>Antigens</subject><subject>Complications</subject><subject>Diabetes</subject><subject>Diabetes mellitus</subject><subject>Diabetes mellitus (non-insulin dependent)</subject><subject>Diabetes Mellitus, Type 2</subject><subject>Enrollments</subject><subject>Guillain-Barre syndrome</subject><subject>Hemagglutination Inhibition Tests</subject><subject>Humans</subject><subject>Immunogenicity</subject><subject>Influenza</subject><subject>Influenza A Virus, H3N2 Subtype</subject><subject>Influenza Vaccines</subject><subject>Influenza, Human - prevention & control</subject><subject>Laboratories</subject><subject>Memory</subject><subject>Middle Aged</subject><subject>Obesity</subject><subject>Older people</subject><subject>Original</subject><subject>Regression analysis</subject><subject>Respiratory diseases</subject><subject>serologic response</subject><subject>Serology</subject><subject>Vaccination</subject><subject>vaccine</subject><subject>Vaccines</subject><subject>Vaccines, Inactivated</subject><subject>Viruses</subject><subject>Vitamin D</subject><issn>1750-2640</issn><issn>1750-2659</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>24P</sourceid><sourceid>EIF</sourceid><sourceid>BENPR</sourceid><recordid>eNp1kd2LVCEYhyWK9qMu-gfiQDd1Mbt-Ho83QSy1DSwEUd2KR9-zuXh0Us_E9NfnNNtQQd74qo-Pr_wQekbwBWnj0uftBaGKsQfolEiBV7QX6uGx5vgEnZVyh7HoB8EfoxPGB6HEwE_RtJ43xtYuTZ3zZoQKpSvV1KV0KXZ-npeYbiF66-tuD9XstyZArJ2P7V5bVHCtnsIC8YfptsZaH6HtdCk4yJ1xS6jlCXo0mVDg6f18jj6_e_vp6v3q5sP1-urNzcpyztgKyOQMMU5aZSclJzM4ORhFOJWMqgGPDCtQXIG0htpRMApcSjoSPiojnGLn6PXBu1nGGZxtjWYT9Cb72eSdTsbrv0-i_6pv01YPamAKD03w8l6Q07cFStWzLxZCMBHSUjTtca8okXj_1ot_0Lu05Ni-1ygusSC92gtfHSibUykZpmMzBOt9erqlp3-l19jnf3Z_JH_H1YDLA_DdB9j936TXH78clD8BVU-mlA</recordid><startdate>202205</startdate><enddate>202205</enddate><creator>Spencer, Sarah</creator><creator>Chung, Jessie R.</creator><creator>Belongia, Edward A.</creator><creator>Sundaram, Maria</creator><creator>Meece, Jennifer</creator><creator>Coleman, Laura A.</creator><creator>Zimmerman, Richard K.</creator><creator>Nowalk, Mary Patricia</creator><creator>Moehling Geffel, Krissy</creator><creator>Ross, Ted</creator><creator>Carter, Chalise E.</creator><creator>Shay, David</creator><creator>Levine, Min</creator><creator>Liepkalns, Justine</creator><creator>Kim, Jin Hyang</creator><creator>Sambhara, Suryaprakash</creator><creator>Thompson, Mark G.</creator><creator>Flannery, Brendan</creator><general>John Wiley & Sons, Inc</general><general>John Wiley and Sons Inc</general><scope>24P</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QL</scope><scope>7T2</scope><scope>7U9</scope><scope>7X7</scope><scope>7XB</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AEUYN</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>C1K</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>H94</scope><scope>K9.</scope><scope>M0S</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0001-9619-4820</orcidid><orcidid>https://orcid.org/0000-0003-1947-7469</orcidid><orcidid>https://orcid.org/0000-0001-6786-3482</orcidid><orcidid>https://orcid.org/0000-0002-2103-4096</orcidid><orcidid>https://orcid.org/0000-0001-5205-966X</orcidid><orcidid>https://orcid.org/0000-0001-8056-3302</orcidid><orcidid>https://orcid.org/0000-0002-1702-2690</orcidid><orcidid>https://orcid.org/0000-0001-7478-0415</orcidid></search><sort><creationdate>202205</creationdate><title>Impact of diabetes status on immunogenicity of trivalent inactivated influenza vaccine in older adults</title><author>Spencer, Sarah ; Chung, Jessie R. ; Belongia, Edward A. ; Sundaram, Maria ; Meece, Jennifer ; Coleman, Laura A. ; Zimmerman, Richard K. ; Nowalk, Mary Patricia ; Moehling Geffel, Krissy ; Ross, Ted ; Carter, Chalise E. ; Shay, David ; Levine, Min ; Liepkalns, Justine ; Kim, Jin Hyang ; Sambhara, Suryaprakash ; Thompson, Mark G. ; Flannery, Brendan</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4433-e1fda1ad7c9cf97fa8d78a9142732980b309e949e7ca2cb532e4772b14b9a5d93</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Adults</topic><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Antibodies</topic><topic>Antibodies, Viral</topic><topic>Antigens</topic><topic>Complications</topic><topic>Diabetes</topic><topic>Diabetes mellitus</topic><topic>Diabetes mellitus (non-insulin dependent)</topic><topic>Diabetes Mellitus, Type 2</topic><topic>Enrollments</topic><topic>Guillain-Barre syndrome</topic><topic>Hemagglutination Inhibition Tests</topic><topic>Humans</topic><topic>Immunogenicity</topic><topic>Influenza</topic><topic>Influenza A Virus, H3N2 Subtype</topic><topic>Influenza Vaccines</topic><topic>Influenza, Human - prevention & control</topic><topic>Laboratories</topic><topic>Memory</topic><topic>Middle Aged</topic><topic>Obesity</topic><topic>Older people</topic><topic>Original</topic><topic>Regression analysis</topic><topic>Respiratory diseases</topic><topic>serologic response</topic><topic>Serology</topic><topic>Vaccination</topic><topic>vaccine</topic><topic>Vaccines</topic><topic>Vaccines, Inactivated</topic><topic>Viruses</topic><topic>Vitamin D</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Spencer, Sarah</creatorcontrib><creatorcontrib>Chung, Jessie R.</creatorcontrib><creatorcontrib>Belongia, Edward A.</creatorcontrib><creatorcontrib>Sundaram, Maria</creatorcontrib><creatorcontrib>Meece, Jennifer</creatorcontrib><creatorcontrib>Coleman, Laura A.</creatorcontrib><creatorcontrib>Zimmerman, Richard K.</creatorcontrib><creatorcontrib>Nowalk, Mary Patricia</creatorcontrib><creatorcontrib>Moehling Geffel, Krissy</creatorcontrib><creatorcontrib>Ross, Ted</creatorcontrib><creatorcontrib>Carter, Chalise E.</creatorcontrib><creatorcontrib>Shay, David</creatorcontrib><creatorcontrib>Levine, Min</creatorcontrib><creatorcontrib>Liepkalns, Justine</creatorcontrib><creatorcontrib>Kim, Jin Hyang</creatorcontrib><creatorcontrib>Sambhara, Suryaprakash</creatorcontrib><creatorcontrib>Thompson, Mark G.</creatorcontrib><creatorcontrib>Flannery, Brendan</creatorcontrib><collection>Wiley Online Library Open Access</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Health and Safety Science Abstracts (Full archive)</collection><collection>Virology and AIDS Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest One Sustainability</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Influenza and other respiratory viruses</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Spencer, Sarah</au><au>Chung, Jessie R.</au><au>Belongia, Edward A.</au><au>Sundaram, Maria</au><au>Meece, Jennifer</au><au>Coleman, Laura A.</au><au>Zimmerman, Richard K.</au><au>Nowalk, Mary Patricia</au><au>Moehling Geffel, Krissy</au><au>Ross, Ted</au><au>Carter, Chalise E.</au><au>Shay, David</au><au>Levine, Min</au><au>Liepkalns, Justine</au><au>Kim, Jin Hyang</au><au>Sambhara, Suryaprakash</au><au>Thompson, Mark G.</au><au>Flannery, Brendan</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Impact of diabetes status on immunogenicity of trivalent inactivated influenza vaccine in older adults</atitle><jtitle>Influenza and other respiratory viruses</jtitle><addtitle>Influenza Other Respir Viruses</addtitle><date>2022-05</date><risdate>2022</risdate><volume>16</volume><issue>3</issue><spage>562</spage><epage>567</epage><pages>562-567</pages><issn>1750-2640</issn><eissn>1750-2659</eissn><abstract>Individuals with type 2 diabetes mellitus experience high rates of influenza virus infection and complications. We compared the magnitude and duration of serologic response to trivalent influenza vaccine in adults aged 50–80 with and without type 2 diabetes mellitus. Serologic response to influenza vaccination was similar in both groups: greater fold‐increases in antibody titer occurred among participants with lower pre‐vaccination antibody titers. Waning of antibody titers was not influenced by diabetes status.</abstract><cop>England</cop><pub>John Wiley & Sons, Inc</pub><pmid>34859584</pmid><doi>10.1111/irv.12933</doi><tpages>6</tpages><orcidid>https://orcid.org/0000-0001-9619-4820</orcidid><orcidid>https://orcid.org/0000-0003-1947-7469</orcidid><orcidid>https://orcid.org/0000-0001-6786-3482</orcidid><orcidid>https://orcid.org/0000-0002-2103-4096</orcidid><orcidid>https://orcid.org/0000-0001-5205-966X</orcidid><orcidid>https://orcid.org/0000-0001-8056-3302</orcidid><orcidid>https://orcid.org/0000-0002-1702-2690</orcidid><orcidid>https://orcid.org/0000-0001-7478-0415</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1750-2640 |
ispartof | Influenza and other respiratory viruses, 2022-05, Vol.16 (3), p.562-567 |
issn | 1750-2640 1750-2659 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8983908 |
source | MEDLINE; Wiley Online Library Open Access; DOAJ Directory of Open Access Journals; Wiley Online Library Journals Frontfile Complete; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; PubMed Central |
subjects | Adults Aged Aged, 80 and over Antibodies Antibodies, Viral Antigens Complications Diabetes Diabetes mellitus Diabetes mellitus (non-insulin dependent) Diabetes Mellitus, Type 2 Enrollments Guillain-Barre syndrome Hemagglutination Inhibition Tests Humans Immunogenicity Influenza Influenza A Virus, H3N2 Subtype Influenza Vaccines Influenza, Human - prevention & control Laboratories Memory Middle Aged Obesity Older people Original Regression analysis Respiratory diseases serologic response Serology Vaccination vaccine Vaccines Vaccines, Inactivated Viruses Vitamin D |
title | Impact of diabetes status on immunogenicity of trivalent inactivated influenza vaccine in older adults |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-28T05%3A44%3A03IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Impact%20of%20diabetes%20status%20on%20immunogenicity%20of%20trivalent%20inactivated%20influenza%20vaccine%20in%20older%20adults&rft.jtitle=Influenza%20and%20other%20respiratory%20viruses&rft.au=Spencer,%20Sarah&rft.date=2022-05&rft.volume=16&rft.issue=3&rft.spage=562&rft.epage=567&rft.pages=562-567&rft.issn=1750-2640&rft.eissn=1750-2659&rft_id=info:doi/10.1111/irv.12933&rft_dat=%3Cproquest_pubme%3E2647051698%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2647051698&rft_id=info:pmid/34859584&rfr_iscdi=true |